People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applied Proteomics, Inc. | — | Biotechnology | Series B | $50.4M | $1.1B | 2013 |
Erik Holmlin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Erik Holmlin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James C. Blair | 1 | 8 |
| James Blair | 1 | 8 |
| Peter Klemm | 1 | 3 |
| David Agus | 1 | 3 |
| Kok Thay Lim | 1 | 2 |
| Daniel Abrutyn | 1 | 1 |
| Daniel Hillis | 1 | 1 |
| Peter C. Klemm | 1 | 1 |
| Erik C. Holmlin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.